Healthcare And Defense Materials Will Steadily Support A Fairly Valued Long Term Outlook

AnalystLowTarget

Analyst Low Target compiles bearish analysts opinions to create narratives which represent one standard deviation below the consensus price target, using forecasted revenue and earnings figures, as well as the transcripts of earnings calls.

Published

10 Jan 26

Updated

14 Jul 26

Views

Not Invested

Shared on 14 Jul 26

Fair value Increased 24%

AVNT: Portfolio Optimization And Offshore Wind Progress May Support Future Re-Rating

Avient’s fair value estimate moves higher as analysts point to progress in reshaping its product mix and improving profitability, with some seeing the shares as still out of favor versus similar companies. New approval for Dyneema use in floating offshore wind in Japan adds a fresh real‑world test of demand, even as others warn the company still has to prove it can deliver consistently.

2 views

Fair Value vs Share Price

US$42

vs US$44.064.9% overvalued

3.5%

Revenue growth

7.9%

Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on Avient

Fair value estimate changes
Narrative and analyst updates
Key company announcements

Company analysis

Established dividend payer and fair value.

Market capUS$4.1b

PB1.7x

Estimated Growth3.8%

Dividend Yield2.5%

Full analysis

CEO & management

Ashish Khandpur

CEO

2.1yrs

CEO Tenure

Operates as a formulator of material solutions in the United States, Canada, Mexico, Europe, South America, and Asia.